Thomas John Charles
Krystal Biotech, Inc. · EVP
Thomas John Charles is listed in filings as EVP at Krystal Biotech, Inc.. This profile follows SEC Form 4 activity through May 27, 2026, including sale activity. Recent filings connect the profile to Krystal Biotech, Inc. (KRYS). The current snapshot covers public activity from May 27, 2026. Reported amounts are shown as $193.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $194k642 shares | SellMay 26, 2026 | $302.03 | $343.79 |